Visualizing size distribution with high resolution! Particle size measurement solution for pharmaceuticals and biopharmaceuticals.
The "TaylorSizer" is a nanoparticle analysis device that provides high-resolution particle size measurement capabilities, allowing for the detection of particles in the range of 0.2 to 400 nm with high precision. Due to its high resolution, the SD-TDA can determine small vesicle aggregates at the protein scale (2-5 nm) as well as larger aggregates (20-40 nm). Additionally, Taylor dispersion analysis (TDA) excels at detecting nanoparticles from extracellular vesicles (EVs) that are difficult to identify with other techniques. Its high resolution and unique sensitivity enable the identification of small-sized protein remnants, markers, and species that may be considered non-vesicular extracellular particles (NVEPs). 【Features】 ■ An analytical method utilizing the combination of solute diffusion and convection in laminar flow within a capillary ■ Measurement of the diffusion coefficient of the solute itself, calculating the hydrodynamic radius (particle size) using the Stokes-Einstein equation ■ Capable of measuring from 0.5 nm to 400 nm ■ Visualization of size distribution with high resolution ■ Rapid evaluation with minute samples *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Partial)】 ■ Size measurement principle: Taylor dispersion analysis (SD-TDA method) ■ Measurement size range (diameter): Approximately 0.5 nm to 400 nm ■ Detection method: UV-visible (190–650 nm DAD), fluorescence detection (Option) ■ Minimum sample amount: Injection volume in nL ■ Temperature control: 5–55°C, measurement section at 15–55° *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Raifiks Analytical Co., Ltd. conducts sales activities nationwide, primarily focusing on pharmaceutical companies. Therefore, we can propose products that align with the latest model information and trends. We offer suggestions for equipment suited to each department, from the drug discovery phase, where unique medications not available from other companies are developed, to production and manufacturing. Our network extends overseas, allowing us to propose products not available through Japanese distributors and to suggest the development of products that do not currently exist in the market. We will provide solutions tailored to our customers' needs.
